All Viruses articles
-
NewsResearchers use ‘brain-on-a-chip’ to revolutionize fight against deadly encephalitis viruses
A transparent chip no larger than a stick of gum is helping scientists transform the way researchers study the human brain and develop treatments for some of the world’s deadliest viruses.
-
NewsSingle-cell movies reveal how host physiology sets phage success - and how to time therapies
A new study outlines how an innovative tool can be used to help uncover the reasons why phages succeed or fail when used to target bacterial infections.
-
NewsMental health conditions may heighten liver cancer risk in veterans due to increased hepatitis C
Mental health conditions, especially alcohol use disorder and post-traumatic stress disorder (PTSD), significantly increase the likelihood of developing liver cancer among U.S. veterans living with cirrhosis of any cause.
-
NewsStudy shows common childhood virus can drive bladder cancer development
Tackling a common childhood virus could open the door to preventing bladder cancer, according to new research. The study suggests that a virus most people pick up in childhood can trigger the type of DNA damage that can lead to bladder cancer later in life.
-
NewsNew test distinguishes vaccine-induced false positives from active HIV infection
A new device correctly identified those with active HIV-1 infection 95% of the time and those without active infection but with vaccine-induced molecules that could trigger a false positive, 98% of the time.
-
NewsStudy links childhood vaccination to lower risk of drug-resistant bacteria
Children in Guatemala who received a common vaccine that helps prevent pneumonia were less likely to carry antibiotic-resistant bacteria, according to a new study examining whether rotavirus (RV) and pneumococcal (PCV13) vaccines reduce gut colonization by a group of bacteria.
-
NewsCommon water pill may help HIV medicines work faster and reduce inflammation, early study suggests
Adding a readily available diuretic to standard HIV therapy appears to reduce circulating virus by four-fold, a new study shows. Researchers treated HIV-infected mice with human immune cells with first‑line antiretroviral therapy plus a long‑acting form of spironolactone.
-
NewsA molecule opens a breach in HIV, providing access to its reservoirs
An international team has unveiled how a molecule capable of opening the “shell” of HIV improves the elimination of infected cells. The study demonstrates how a new CD4-mimetic compound, CJF-III-288, modifies the HIV envelope protein structure to allow for a better immune response.
-
NewsResearchers identify why some people with HIV achieve remission after antibody treatment
Researchers have discovered why some people living with HIV who are given broadly neutralizing anti-HIV antibodies (bNAbs) can safely stop taking standard, lifelong HIV medications and maintain control of the virus for years, while others given the same treatment do not achieve this remission.
-
NewsVIRE: a global data platform to better understand viruses
Researchers have released a comprehensive viral genome database covering diverse ecosystems to advance the understanding of viral evolution and ecosystem functions.
-
NewsThe immune system creates its own targets within viruses
A new study reveals that our immune system does more than defend against viruses. In certain cases, it induces mutations within viruses that make them easier to recognize later on.
-
NewsHow reactive oxygen species target viruses differently: new clues for safer water disinfection
A new study systematically explored how reactive oxygen species (ROS) inactivate viruses with distinct structures. The results revealed clear heterogeneity: enveloped RNA viruses were most susceptible to oxidation, while double-stranded DNA viruses showed strong resistance.
-
NewsMucosal virome and host transcriptome interactions reveal viral influence in colorectal polyp development
A new study has provided the first integrated mucosal virome-transcriptome landscape of colorectal polyps, the precursors of colorectal cancer, offering new insights into viral-host interactions at this early disease stage.
-
NewsA viral fitness-constraint strategy exploits the structural and functional limitations of viral evolution
Researchers have revealed two innovative strategies for the development of durable and broadly neutralizing antibodies against SARS-CoV-2. Their study proposes the immune trajectory strategy and the viral fitness-constraint strategy.
-
NewsTreatment and prevention of HIV/AIDS: infectious disease experts talk unfinished business
As the world marks World AIDS Day, world-renowned infectious disease expert Anthony Fauci, MD, and Greg Folkers, MS, MPH, highlight advances made in the treatment and prevention of HIV, but caution ’History will judge us harshly should we squander this opportunity’.
-
NewsLong-term HIV control: Could this combination therapy be the key?
A new study shows it may be possible to control HIV without long-term antiviral treatment — an advance that points the way toward a possible cure for a disease that affects 40 million people around the world.
-
NewsMeasles deaths down 88% since 2000, but cases surge
Global immunization efforts have led to an 88% drop in measles deaths between 2000 and 2024, according to a new report from the World Health Organization (WHO). Nearly 59 million lives have been saved by the measles vaccine since 2000.
-
News Lack of dietary iron may impair immune cells’ ability to fight influenza
New research suggests that a lack of dietary iron can negatively affect the ability of immune cells to respond to viral infection in the lungs. In mice with dietary iron deficiency and influenza, immune cells struggled to produce a key signal needed to fight viruses and did not regain this ability.
-
NewsNew prevention tools and investment in services essential in the fight against AIDS
On World AIDS Day, the World Health Organization (WHO) calls on governments and partners to rapidly expand access to new WHO-approved tools including lenacapavir (LEN) to drive down infections and counter disruption to essential health services caused by cuts to foreign aid.
-
NewsHalf of all people living with HIV in Europe are diagnosed late
Europe is failing to test and treat HIV early, with over half of all diagnoses in 2024 being made too late for optimal treatment, according to new data from ECDC and WHO/Europe.